SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing high volatility as investors weigh stronger-than-expected revenue guidance against the company's decision to launch a 75 million share offering. Community discussion is sharply divided between long-term supporters viewing the capital raise as a necessary step to secure government manufacturing loans and frustrated traders criticizing management for diluting shares and stalling positive price momentum.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors react to a significant earnings beat and raised guidance, highlighting the company's growing role as a critical partner in the AI infrastructure and memory stack. Community sentiment is high, with active discussions focused on its strategic positioning within the NVIDIA ecosystem and the potential for a sustained multi-year growth cycle.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a sharp surge in price driven by a strategic 380-megawatt clean power agreement for data centers and the securing of a non-dilutive $49 million financing package from the U.S. Export-Import Bank. The community is actively discussing the stock's transition into momentum mode, with long-term shareholders debating whether this growth signals a sustained reversal or a familiar cycle of dilution and volatility.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing intense community speculation and active trading volume driven by persistent buyout rumors and strategic shifts, including the closure of its internal discovery center to focus on capital-efficient partnerships. Traders are closely monitoring short interest and recent technical momentum, as investors weigh potential M&A scenarios against the company's long-term commercial execution.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as momentum builds around its GLP-1/GIP obesity pipeline, with community members actively discussing a potential buyout or major partnership as institutional accumulation appears to intensify. Investors are eagerly front-running key upcoming clinical data readouts, fueling speculation about the stock's ability to challenge its 52-week highs and capture significant market share.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is attracting significant attention as investors react to its new joint manufacturing venture with Toyota and ongoing FAA certification progress for its electric air taxi. The community is actively debating the stock's potential as a long-term asymmetric play while navigating volatility, with many traders focused on critical support levels and the company's capital runway as it pushes toward commercialization.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the FDAs accelerated approval of its lead drug, TRUTAKNA (atacicept), for the treatment of adults with primary IgA nephropathy. While the community is debating the muted post-approval price action, investors remain focused on the drug's commercial potential as the first dual BAFF/APRIL inhibitor in a competitive market.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense community scrutiny and volatility, driven by a proposed reverse stock split and ongoing debates regarding the company's association with the Trump family and its financial management. Investors are actively discussing the stock's significant decline from its highs, questioning the firm's operational transparency, and debating the potential impact of legislative developments like the Clarity Act on its future performance.

Alight, Inc. engages in the provision of cloud-based integrated digital human capital and business solutions. The company was founded on June 01, 2017 and is headquartered in Chicago, IL.

Alight Inc. - Ordinary Shares - Class A

Alight Inc. 

Alight is trending due to the completion of a 1-for-20 reverse stock split, an event that has sparked intense debate among investors regarding its potential as a turnaround opportunity or a sign of deeper financial distress. The community is actively discussing the split's impact on institutional interest and share price stability, while remains divided over whether the stock's current valuation represents a high-risk buying opportunity or a signal of long-term decline.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is gaining significant momentum as investors anticipate the final Phase 3 durability data for its COMP360 treatment, which is critical for an upcoming FDA NDA submission. The community is actively debating the stock's potential for a major re-rating, fueled by recent board appointments, executive-level optimism about commercialization, and the broader institutional rotation into biotech stocks with significant clinical catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Itron (ITRI) Exceeds Market Returns: Some Facts to Consider

Itron (ITRI) reached $86.74 at the closing of the latest trading day, reflecting a +1.92% change compared to its last close.

How Itron, Inc. (ITRI) Fits the Utility Digitization Trade Through Auckland's Smart Meter Upgrade

How Itron, Inc. (ITRI) Fits the Utility Digitization Trade Through Auckland's Smart Meter Upgrade...

Why the Market Dipped But Itron (ITRI) Gained Today

Itron (ITRI) closed the most recent trading day at $83.87, moving +1.11% from the previous trading session.

Itron (ITRI) Increases Despite Market Slip: Here's What You Need to Know

Itron (ITRI) closed the most recent trading day at $82.95, moving +1.64% from the previous trading session.

Wall Street Bulls Look Optimistic About Itron (ITRI): Should You Buy?

Based on the average brokerage recommendation (ABR), Itron (ITRI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Itron (ITRI) concluded the recent trading session at $80.81, signifying a +1.96% move from its prior day's close.

What Makes Itron (ITRI) a Short Position?

What Makes Itron (ITRI) a Short Position...

Itron (ITRI) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest trading session, Itron (ITRI) closed at $79.26, marking a -2.27% move from the previous day.

Here's Why Itron (ITRI) Gained But Lagged the Market Today

The latest trading day saw Itron (ITRI) settling at $80.73, representing a +1.31% change from its previous close.

Itron (ITRI) Stock Moves -1.21%: What You Should Know

The latest trading day saw Itron (ITRI) settling at $80.07, representing a -1.21% change from its previous close.

Itron, Inc. is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems. The Networked Solutions segment offers a combination of communication devices, network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. The Outcomes segment consists of the firm’s value-added, enhanced software and services operating segment. The company was founded in 1977 and is headquartered in Liberty Lake, WA.

Itron Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$84.44
Prev Close	$86.74
Open	$86.55
Dividend Yield	0.00%
50-Day Moving Average	$82.82
Beta	1.19
Avg. Volume	683,265.74
PE Ratio	13.85

52-Week High	$142.00
52-Week Low	$77.77
Market Capitalization	$3.85B
EPS (Annual)	$6.50
Price to Book	2.39
Revenue Per Employee	$426,521.44

Feed

News

Sentiment

Earnings

Fundamentals

Info

ITRIItron Inc.

Latest ITRI News